Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail
-

Staff

 Christine Moore, Ph.D., Acting Director

Phone:

(301) 796-1900

Fax: 

(301) 796-9748

Email: 

Christine.Moore@fda.hhs.gov

U.S. Mail: 

10903 New Hampshire Avenue HFD-800
Silver Spring, MD 20993

Dr. Moore is the Acting Office Director and Deputy Director for Science and Policy for FDA's Office of New Drug Quality Assessment. She started at the agency in 2004 as the Branch Chief of the newly created Manufacturing Science group. Christine has been actively involved in FDA's Quality by Design efforts and was a member of the expert working group for ICH Q8(R). Prior to joining the FDA, she worked for 10 years in API process development and scale-up at Pfizer and Searle/Pharmacia. Her background is in chemical and biochemical engineering, with degrees from Northwestern University and Massachusetts Institute of Technology.

 

 Elaine Morefield, Ph.D., Deputy Director 

Phone:

(301) 796-1900

Fax: 

(301) 796-9748

Email: 

Elaine.Morefield@fda.hhs.gov

U.S. Mail: 

10903 New Hampshire Avenue HFD-800
Silver Spring, MD 20993

Dr. Elaine Morefield is currently the Deputy Office Director for Review and Operations in the Office of New Drug Quality Assessment at the US Food and Drug Administration. Previously she was the Director of the Pre-Marketing Assessment Division II, in the Office of New Drug Quality Assessment at the US FDA. Dr. Morefield obtained her Ph.D. in Industrial and Physical Pharmacy from Purdue University. She has over 20 years experience in the pharmaceutical industry working in drug product development with such companies as Wyeth Healthcare, Schering-Plough, and DSM Pharmaceuticals.

-
-